Fonte: Brazilian Journal of Biology. Unidade: FCF
Assuntos: CÉLULAS ENDOTELIAIS, CULTURA DE CÉLULAS
ABNT
LOPES, José Emilio Fehr Pereira et al. In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate. Brazilian Journal of Biology, v. 70, n. 2, p. 443-449, 2010Tradução . . Disponível em: https://doi.org/10.1590/s1519-69842010000200029. Acesso em: 19 nov. 2024.APA
Lopes, J. E. F. P., Barbosa, M. R., Stella, C. N., Santos, W. A., Pereira, E. M., Nogueira Neto, J., et al. (2010). In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate. Brazilian Journal of Biology, 70( 2), 443-449. doi:10.1590/s1519-69842010000200029NLM
Lopes JEFP, Barbosa MR, Stella CN, Santos WA, Pereira EM, Nogueira Neto J, Augusto EM, Silva LV, Smaili SS, Gomes LF. In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate [Internet]. Brazilian Journal of Biology. 2010 ; 70( 2): 443-449.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s1519-69842010000200029Vancouver
Lopes JEFP, Barbosa MR, Stella CN, Santos WA, Pereira EM, Nogueira Neto J, Augusto EM, Silva LV, Smaili SS, Gomes LF. In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate [Internet]. Brazilian Journal of Biology. 2010 ; 70( 2): 443-449.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1590/s1519-69842010000200029